NM_004560.4:c.1710G>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_004560.4(ROR2):​c.1710G>A​(p.Pro570Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0369 in 1,611,576 control chromosomes in the GnomAD database, including 1,234 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.027 ( 86 hom., cov: 33)
Exomes 𝑓: 0.038 ( 1148 hom. )

Consequence

ROR2
NM_004560.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -3.38

Publications

5 publications found
Variant links:
Genes affected
ROR2 (HGNC:10257): (receptor tyrosine kinase like orphan receptor 2) The protein encoded by this gene is a receptor protein tyrosine kinase and type I transmembrane protein that belongs to the ROR subfamily of cell surface receptors. The protein may be involved in the early formation of the chondrocytes and may be required for cartilage and growth plate development. Mutations in this gene can cause brachydactyly type B, a skeletal disorder characterized by hypoplasia/aplasia of distal phalanges and nails. In addition, mutations in this gene can cause the autosomal recessive form of Robinow syndrome, which is characterized by skeletal dysplasia with generalized limb bone shortening, segmental defects of the spine, brachydactyly, and a dysmorphic facial appearance. [provided by RefSeq, Jul 2008]
ROR2 Gene-Disease associations (from GenCC):
  • brachydactyly type B1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive Robinow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 9-91724784-C-T is Benign according to our data. Variant chr9-91724784-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 159811.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.38 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0273 (4161/152300) while in subpopulation NFE AF = 0.0431 (2933/68020). AF 95% confidence interval is 0.0418. There are 86 homozygotes in GnomAd4. There are 1998 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 86 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ROR2NM_004560.4 linkc.1710G>A p.Pro570Pro synonymous_variant Exon 9 of 9 ENST00000375708.4 NP_004551.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ROR2ENST00000375708.4 linkc.1710G>A p.Pro570Pro synonymous_variant Exon 9 of 9 1 NM_004560.4 ENSP00000364860.3
ROR2ENST00000375715.5 linkc.1290G>A p.Pro430Pro synonymous_variant Exon 9 of 13 1 ENSP00000364867.1
ROR2ENST00000550066.5 linkn.2178G>A non_coding_transcript_exon_variant Exon 11 of 11 2

Frequencies

GnomAD3 genomes
AF:
0.0273
AC:
4159
AN:
152182
Hom.:
86
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00729
Gnomad AMI
AF:
0.0746
Gnomad AMR
AF:
0.0194
Gnomad ASJ
AF:
0.00547
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0159
Gnomad FIN
AF:
0.0393
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0431
Gnomad OTH
AF:
0.0201
GnomAD2 exomes
AF:
0.0274
AC:
6847
AN:
250032
AF XY:
0.0280
show subpopulations
Gnomad AFR exome
AF:
0.00629
Gnomad AMR exome
AF:
0.0122
Gnomad ASJ exome
AF:
0.00650
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0396
Gnomad NFE exome
AF:
0.0416
Gnomad OTH exome
AF:
0.0239
GnomAD4 exome
AF:
0.0379
AC:
55361
AN:
1459276
Hom.:
1148
Cov.:
43
AF XY:
0.0371
AC XY:
26891
AN XY:
725408
show subpopulations
African (AFR)
AF:
0.00583
AC:
195
AN:
33448
American (AMR)
AF:
0.0116
AC:
519
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.00652
AC:
170
AN:
26078
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39628
South Asian (SAS)
AF:
0.0182
AC:
1572
AN:
86204
European-Finnish (FIN)
AF:
0.0380
AC:
2020
AN:
53150
Middle Eastern (MID)
AF:
0.0163
AC:
94
AN:
5760
European-Non Finnish (NFE)
AF:
0.0440
AC:
48829
AN:
1110038
Other (OTH)
AF:
0.0325
AC:
1958
AN:
60294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
3616
7231
10847
14462
18078
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1790
3580
5370
7160
8950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0273
AC:
4161
AN:
152300
Hom.:
86
Cov.:
33
AF XY:
0.0268
AC XY:
1998
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00727
AC:
302
AN:
41566
American (AMR)
AF:
0.0195
AC:
298
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00547
AC:
19
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.0162
AC:
78
AN:
4828
European-Finnish (FIN)
AF:
0.0393
AC:
417
AN:
10618
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0431
AC:
2933
AN:
68020
Other (OTH)
AF:
0.0199
AC:
42
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
206
411
617
822
1028
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0352
Hom.:
206
Bravo
AF:
0.0244
Asia WGS
AF:
0.0110
AC:
39
AN:
3478
EpiCase
AF:
0.0355
EpiControl
AF:
0.0373

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive Robinow syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Brachydactyly type B1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.21
DANN
Benign
0.74
PhyloP100
-3.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41277837; hg19: chr9-94487066; COSMIC: COSV107484880; API